(Q24203871)

English

Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondyloarthritis) and gastrointestinal or liver comorbidity

scientific article

In more languages

Statements

scholarly article

0 references

Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondyloarthritis) and gastrointestinal or liver comorbidity (English)

0 references

0 references

pain management

0 references

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

psoriatic arthritis

1 reference

based on heuristic

inferred from title

ankylosing spondylitis

1 reference

based on heuristic

inferred from title

Rachelle Buchbinder

3

0 references

Désirée van der Heijde

5

object named as

Désirée van der Heijde

0 references

2

object named as

Sofia Ramiro

0 references

6

object named as

Daniel Aletaha

0 references

author name string

Helga Radner

1

0 references

Robert BM Landewé

4

0 references

publication date

18 January 2012

0 references

Cochrane Database of Systematic Reviews

0 references

An Open Trial of Naproxen in Rheumatoid Arthritis Patients with Significant Esophageal, Gastric, and Duodenal Lesions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Upper gastroduodenal ulceration in arthritis patients treated with celecoxib

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

The safety of lumiracoxib when used in the treatment of arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Therapeutic uses of azapropazone (Rheumox).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

A Double-Blind Crossover Evaluation of Ketoprofen (Orudis®) and Placebo in Rheumatoid Arthritis with Assessment of Long-Term Tolerance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Aceclofenac in rheumatoid arthritis: a useful and novel anti-inflammatory.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

A six-month follow-up study of a slow-release indomethacin tablet in rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Systematic review: coxibs, non-steroidal anti-inflammatory drugs or no cyclooxygenase inhibitors in gastroenterological high-risk patients?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Comparative study of the efficacy and safety of aceclofenac and tenoxicam in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Efficacy and safety of piroxicam revisited. A global meta-analysis of randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Antiinflammatory drugs and gastrointestinal bleeding: a comparison of aspirin and ibuprofen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Comparative clinical trial with a new substance, Diftalone, versus indomethacin in 30 patients affected with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Hepatic and renal tolerability of long-term naproxen treatment in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Gastrointestinal effects of selective and non-selective non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Hepatotoxicity following the therapeutic use of antipyretic analgesics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

The therapeutic use of acetaminophen in patients with liver disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian rheumatology association database

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Gastrointestinal side effects in chronic opioid users: results from a population-based survey

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Treatment of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Comorbidities in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Co-morbidity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Women with established rheumatoid arthritis perceive pain as the predominant impairment of health status

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

NSAID-induced gastrointestinal and cardiovascular injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Paracetamol, alcohol and the liver

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

21 January 2018

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of diflunisal and phenylbutazone in the treatment of ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase-2 inhibitors in patients with high gastrointestinal risk: are we there yet?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Salicylate hepatotoxicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of Ketoprofen and Naproxen in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

A short-term double-blind controlled trial of prenazone (DA 2370) in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

A Long-Term Study of Benorylate in Patients with Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety of Arthrotec in patients with rheumatoid arthritis or osteoarthritis: an assessment of the upper gastrointestinal tract by endoscopy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: A systematic literature review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008951.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD008951.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24203871&oldid=1524482610"